BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2108405)

  • 21. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human homologues of Fim1, Fim2/c-Fms, and Fim3, three retroviral integration regions involved in mouse myeloblastic leukemias, are respectively located on chromosomes 6p23, 5q33, and 3q27.
    Van Cong N; Fichelson S; Gross MS; Sola B; Bordereaux D; de Tand MF; Guilhot S; Gisselbrecht S; Frézal J; Tambourin P
    Hum Genet; 1989 Feb; 81(3):257-63. PubMed ID: 2921036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
    Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
    Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. His-1 and His-2: identification and chromosomal mapping of two commonly rearranged sites of viral integration in a myeloid leukemia.
    Askew DS; Bartholomew C; Buchberg AM; Valentine MB; Jenkins NA; Copeland NG; Ihle JN
    Oncogene; 1991 Nov; 6(11):2041-7. PubMed ID: 1682866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
    Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
    Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG.
    Funabiki T; Kreider BL; Ihle JN
    Oncogene; 1994 Jun; 9(6):1575-81. PubMed ID: 8183551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL).
    Royer-Pokora B; Rogers M; Zhu TH; Schneider S; Loos U; Bölitz U
    Oncogene; 1995 Apr; 10(7):1353-60. PubMed ID: 7731686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
    Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
    Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
    Morishita K; Parganas E; William CL; Whittaker MH; Drabkin H; Oval J; Taetle R; Valentine MB; Ihle JN
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3937-41. PubMed ID: 1570317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.
    Morishita K; Parganas E; Parham DM; Matsugi T; Ihle JN
    Oncogene; 1990 Sep; 5(9):1419-23. PubMed ID: 1699199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
    Lennon PA; Abruzzo LV; Medeiros LJ; Cromwell C; Zhang X; Yin CC; Kornblau SM; Konopieva M; Lin P
    Cancer Genet Cytogenet; 2007 Aug; 177(1):37-42. PubMed ID: 17693189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EVI-1 gene--its role in pathogenesis of human leukemias.
    Jółkowska J; Witt M
    Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia.
    von Lindern M; van Agthoven T; Hagemeijer A; Adriaansen H; Grosveld G
    Oncogene; 1989 Jan; 4(1):75-9. PubMed ID: 2644612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
    Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
    Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral integration in murine myeloid tumors to identify Evi-1, a novel locus encoding a zinc-finger protein.
    Copeland NG; Jenkins NA
    Adv Cancer Res; 1990; 54():141-57. PubMed ID: 2105003
    [No Abstract]   [Full Text] [Related]  

  • 36. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
    Kilbey A; Bartholomew C
    Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias.
    Fontenay-Roupie M; Bouscary D; Melle J; Viguié F; Picard F; Guesnu M; Dreyfus F
    Hematol Cell Ther; 1997 Feb; 39(1):5-10. PubMed ID: 9088932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
    Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
    Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
    Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
    Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
    Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
    Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.